Clinical Trials Directory

Trials / Completed

CompletedNCT01980251

Delirium, Electroencephalographic Alterations and Cortical Spreading Depression (CSD) in Critical Illness

Delirium, Electroencephalographic Alterations and Cortical Spreading Depression in Critical Illness

Status
Completed
Phase
Study type
Observational
Enrollment
102 (actual)
Sponsor
Glostrup University Hospital, Copenhagen · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Delirium in the intensive care unit is an acutely developed brain dysfunction affecting up to 80 % of patients. It is associated with significantly increased morbidity and mortality during admission and post-discharge. The mechanism behind the condition is poorly understood but assumably multifactorial, and the purpose of this study is to investigate the pathophysiology further.

Detailed description

The pathophysiology behind delirium in critical illness is not clarified but assumed to involve inflammation, changes in cerebral perfusion and neurotransmission, sleep deprivation and the use of i.e. sedatives. Cortical spreading depression is a phenomenon occuring in critically ill patients with acute cerebral trauma and likely associated with significant secondary neuron damage. The hypothesis is that 1. Delirium in critically ill patients without acute cerebral damage is a clinical manifestation of cortical spreading depression and can be recorded in a noninvasive direct current-electroencephalography 2. Electroencephalographic alterations or potentially specific signatures occur in delirium and thus, delirium can be predicted by recording continuous alternate current electroencephalography on admission in an ICU

Conditions

Timeline

Start date
2013-10-01
Primary completion
2015-09-01
Completion
2015-09-01
First posted
2013-11-08
Last updated
2016-08-04

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT01980251. Inclusion in this directory is not an endorsement.